Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe Asthma

NCT04048343 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Asthma

Interventions

DRUG: Biological: Experimental: Tezepelumab

Sponsor

AstraZeneca

Collaborators

[object Object]